34573-36-9Relevant articles and documents
PRODRUGS OF MYELOPEROXIDASE INHIBITORS
-
Page/Page column 113, (2021/04/17)
Disclosed are prodrugs of myeloperoxidase (MPO) inhibitors, methods of treating MPO related disorders, e.g., multiple system atrophy, amyotrophic lateral sclerosis, and Huntingtons disease, and methods of neuroprotection, which include administering to a
POMALIDOMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR
-
Paragraph 0060-0061, (2020/07/14)
Disclosed in the present invention are a Pomalidomide derivative and a preparation method therefor. Specifically, the present invention relates to the Pomalidomide derivative and a stereoisomer thereof, or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating cancers.
POMALIDOMIDE DERIVATIVES AND THE PREPARING METHOD THEREOF
-
Paragraph 0042-0044, (2019/08/01)
The invention relates to pomalidomide derivatives and their stereoisomers or pharmaceutically acceptable salts, and their use in preparing medicaments for treating cancers.